Cosmos Health Inc. (COSM) Insider Trading Activity

NASDAQ$0.5245
Market Cap
$14.28M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
102 of 893
Rank in Industry
2 of 50

COSM Insider Trading Activity

COSM Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$2,134,977
28
100
Sells
$0
0
0

Related Transactions

Siokas GrigoriosChief Executive Officer
30
$2.2M
0
$0
$2.2M

About Cosmos Health Inc.

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Insider Activity of Cosmos Health Inc.

Over the last 12 months, insiders at Cosmos Health Inc. have bought $2.13M and sold $0 worth of Cosmos Health Inc. stock.

On average, over the past 5 years, insiders at Cosmos Health Inc. have bought $2.93M and sold $996,724 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Siokas Grigorios (Chief Executive Officer) — $2.2M.

The last purchase of 493,495 shares for transaction amount of $220,000 was made by Siokas Grigorios (Chief Executive Officer) on 2026‑01‑14.

List of Insider Buy and Sell Transactions, Cosmos Health Inc.

2026-01-14PurchaseSiokas GrigoriosChief Executive Officer
493,495
1.8125%
$0.45
$220,000
+10.24%
2026-01-12PurchaseSiokas GrigoriosChief Executive Officer
113,185
0.4157%
$0.50
$57,000
-7.17%
2026-01-08PurchaseSiokas GrigoriosChief Executive Officer
156,190
0.5736%
$0.52
$81,000
+0.34%
2026-01-07PurchaseSiokas GrigoriosChief Executive Officer
124,880
0.4605%
$0.52
$65,000
-0.36%
2026-01-06PurchaseSiokas GrigoriosChief Executive Officer
133,953
0.4983%
$0.54
$72,000
-3.34%
2025-12-19PurchaseSiokas GrigoriosChief Executive Officer
88,314
0.3243%
$0.49
$43,000
+6.65%
2025-12-15PurchaseSiokas GrigoriosChief Executive Officer
168,472
0.6249%
$0.42
$70,000
+23.86%
2025-11-28PurchaseSiokas GrigoriosChief Executive Officer
76,360
0.2804%
$0.64
$49,000
-21.32%
2025-11-25PurchaseSiokas GrigoriosChief Executive Officer
55,732
0.1897%
$0.63
$35,000
-19.27%
2025-11-21PurchaseSiokas GrigoriosChief Executive Officer
56,080
0.1881%
$0.68
$38,000
-24.63%
2025-11-20PurchaseSiokas GrigoriosChief Executive Officer
51,315
0.1721%
$0.62
$32,000
-17.82%
2025-11-19PurchaseSiokas GrigoriosChief Executive Officer
61,614
0.2066%
$0.65
$40,000
-20.78%
2025-05-23PurchaseSiokas GrigoriosChief Executive Officer
34,004
0.1183%
$0.45
$15,217
+45.07%
2025-05-22PurchaseSiokas GrigoriosChief Executive Officer
141,825
0.4933%
$0.44
$62,800
+46.59%
2025-05-21PurchaseSiokas GrigoriosChief Executive Officer
174,172
0.6058%
$0.47
$82,000
+37.85%
2025-05-20PurchaseSiokas GrigoriosChief Executive Officer
147,563
0.5132%
$0.45
$65,961
+44.37%
2025-05-19PurchaseSiokas GrigoriosChief Executive Officer
79,254
0.2757%
$0.43
$34,000
+49.58%
2025-04-24PurchaseSiokas GrigoriosChief Executive Officer
431,852
1.5851%
$0.40
$173,000
+37.33%
2025-04-24PurchaseSiokas GrigoriosChief Executive Officer
254,618
0.9346%
$0.40
$102,000
+37.33%
2025-04-24PurchaseSiokas GrigoriosChief Executive Officer
177,234
0.6505%
$0.40
$71,000
+37.33%
Total: 108
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Siokas GrigoriosChief Executive Officer
7738474
28.421%
$4.06M5336
<0.0001%
MAVROGIANNIS VASILEIOS10 percent owner
9700227
35.6258%
$5.09M28
DRAKOPOULOS PANAGIOTISCEO
8758561
32.1674%
$4.59M07
Terzis GeorgiosChief Financial Officer
727263
2.671%
$381,449.4410
+6%
GOLDSTEIN PETER
157100
0.577%
$82,398.9510
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$2,058,674
1631
-10.96%
$69.55M
$125,860,243
57
-4.48%
$37.72M
$2,767,882
51
8.70%
$27.28M
$30,218,950
47
-3.19%
$25.81M
$33,884,330
45
12.58%
$471.2M
$97,642,477
41
-10.58%
$337.06M
$6,021,989
30
-0.17%
$328.7M
$425,174,478
30
-8.33%
$14.8M
$32,539,771
28
33.37%
$177.72M
Cosmos Health Inc.
(COSM)
$4,304,981
12
-7.52%
$14.28M
$919,520
11
86.29%
$9.29M
$758,061
9
60.03%
$184.63M
$26,692
7
-31.27%
$20.52M
$8,171,353
7
-14.29%
$18.95M
$208,823
7
-1.10%
$73.66M
$489,093
4
59.54%
$649,125.00
$1,030,757
4
-32.95%
$3.56M
$12,203,133
3
25.43%
$307.97M
$10,000
1
-96.58%
$5.99M

COSM Institutional Investors: Active Positions

Increased Positions12+54.55%414,386+41.22%
Decreased Positions8-36.36%203,256-20.22%
New Positions7New147,233New
Sold Out Positions4Sold Out51,660Sold Out
Total Postitions26+18.18%1M+21%

COSM Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$138.000.72%267,79700%2025-09-30
Vanguard Group Inc$121.000.64%235,742+100,908+74.84%2025-09-30
Citadel Advisors Llc$116.000.61%225,507+128,776+133.13%2025-09-30
Geode Capital Management, Llc$102.000.54%198,684+7,124+3.72%2025-09-30
Renaissance Technologies Llc$48.000.25%92,800+92,800New2025-09-30
Xtx Topco Ltd$34.000.18%65,493+28,791+78.44%2025-09-30
State Street Corp$13.000.07%24,74300%2025-09-30
Northern Trust Corp$11.000.06%20,55400%2025-09-30
Susquehanna International Group, Llp$11.000.06%20,514+20,514New2025-09-30
Stonex Group Inc.$10.000.05%19,300+19,300New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.